semaglutide weight loss clinic media Semaglutide: Transform Your Health & Semaglutide GLP-1 Injections for Weight

Veronese, N

Make sure you have a thorough discussion with your healthcare provider to weigh the potential benefits and risks based on you health profile

In phase 2 clinical trials, patients were given a low dose (1 mg) of retatrutide initially, and the dosage was increased slowly and gradually to reduce the risk of side effects

Yesclinical trials and real-world data support long-term semaglutide use for weight management

These included gallbladder cancer (HR = 0.35), meningioma (HR = 0.37), pancreatic cancer (HR = 0.41), hepatocellular carcinoma (HR = 0.47), ovarian cancer (HR = 0.52), colorectal cancer (HR = 0.54), multiple myeloma (HR = 0.59), esophageal cancer (HR = 0.60), endometrial cancer (HR = 0.74), and kidney cancer (HR = 0.76)